Moberg Pharma AB (publ) (STO:MOB)
9.40
-0.05 (-0.53%)
Jul 6, 2026, 2:29 PM CET
Moberg Pharma AB Employees
Moberg Pharma AB had 5 employees as of March 31, 2026. The number of employees decreased by 4 or -44.44% compared to the same quarter last year.
Employees
5
Change
-4
Growth
-44.44%
Revenue / Employee
2.92M SEK
Profits / Employee
-5.15M SEK
Market Cap
444.16M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 5 | -4 | -44.44% |
| Dec 31, 2025 | 5 | -5 | -50.00% |
| Sep 30, 2025 | 6 | -3 | -33.33% |
| Jun 30, 2025 | 9 | 0 | - |
| Mar 31, 2025 | 9 | 0 | - |
| Dec 31, 2024 | 10 | 0 | - |
| Sep 30, 2024 | 9 | 0 | - |
| Jun 30, 2024 | 9 | 0 | - |
| Mar 31, 2024 | 9 | 0 | - |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Sep 30, 2023 | 9 | 1 | 12.50% |
| Jun 30, 2023 | 9 | 1 | 12.50% |
| Mar 31, 2023 | 9 | 1 | 12.50% |
| Dec 31, 2022 | 7 | -1 | -12.50% |
| Sep 30, 2022 | 8 | 1 | 14.29% |
| Jun 30, 2022 | 8 | -3 | -27.27% |
| Mar 31, 2022 | 8 | -3 | -27.27% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orexo AB | 65 |
| EQL Pharma AB | 60 |
| Enzymatica AB | 21 |
| Cinclus Pharma Holding AB | 17 |
| Nanexa AB | 16 |
| Cereno Scientific AB | 10 |
| Newbury Pharmaceuticals AB | 7 |
| Dicot Pharma AB | 4 |
Moberg Pharma AB News
- 7 weeks ago - Moberg Pharma AB Quarterly report: Q1 2026 - Filings
- 4 months ago - Moberg Pharma AB Slides: FY 2026 - Filings
- 4 months ago - Moberg Pharma AB Quarterly report: Q4 2025 - Filings
- 4 months ago - Moberg Pharma AB Annual report: Q4 2025 - Filings
- 4 months ago - Moberg Pharma AB Slides: Investor presentation - Filings
- 8 months ago - Moberg Pharma AB Quarterly report: Q3 2025 - Filings
- 8 months ago - Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential - PRNewsWire
- 11 months ago - Moberg Pharma AB Quarterly report: Q2 2025 - Filings